Categories AlphaGraphs, Earnings, Health Care
PFE Earnings: All you need to know about Pfizer’s Q3 2025 earnings results
Pfizer Inc. (NYSE: PFE) reported its third quarter 2025 earnings results today.
Revenues were $16.7 billion, down 6% on a reported basis and 7% on an operational basis year-over-year.
Net income decreased 21% to $3.5 billion, or $0.62 per share, compared to last year. Adjusted EPS declined 18% to $0.87.
Revenue and earnings beat expectations.
For the full year of 2025, Pfizer expects revenue of $61-64 billion. Adjusted EPS is now expected to be $3.00-3.15.
The stock stayed red during premarket hours on Tuesday.
Prior performance
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
GS Earnings: A snapshot of Goldman Sachs’ Q4 2025 results
Banking giant Goldman Sachs Group, Inc. (NYSE: GS) on Thursday reported lower revenues and higher earnings for the fourth quarter of fiscal 2025. Net revenues decreased to $13.45 billion in
Morgan Stanley (MS) Q4 2025 Earnings: Revenue and profits beat estimates
Morgan Stanley (NYSE: MS) reported its fourth quarter 2025 earnings results today. Net revenues increased 10% year-over-year to $17.9 billion. Net income applicable to common shareholders was $4.3 billion, or
Key highlights from BlackRock’s (BLK) Q4 2025 earnings results
BlackRock, Inc. (NYSE: BLK) reported its fourth quarter 2025 earnings results today. Revenue increased 23% year-over-year to $7 billion. Net income decreased 33% to $1.13 billion, or $7.16 per share,
